Combined modality therapy (CMT) using concurrent radiation therapy (RT) with paclitaxel based chemotherapeutic regimen in unresectable locally advanced nonsmall cell lung cancer (LANSCLC) ; long term follow up on three sequential multi-institutional prospective phase II studies

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

  • CRID
    1572261550018444800
  • NII論文ID
    10012810177
  • データソース種別
    • CiNii Articles

問題の指摘

ページトップへ